We develop Transformative Therapies Targeting Metabolic Checkpoints to Reprogram the Immune System and Address Hard-to-Treat Diseases

Pilatus Biosciences is advancing a robust pipeline of first-in-class therapies designed to tackle the immune and metabolic challenges underlying cancer and other immune-related diseases. With cutting-edge science and a focus on the tumor microenvironment, our therapies aim to deliver life-changing outcomes for patients facing limited treatment options.